


If you’ve been anywhere near a health news feed lately, you’ve seen the headlines. AI detects Alzheimer’s years early. Machine learning outperforms doctors at reading brain scans. Speech patterns reveal dementia before symptoms appear. It’s a lot, and it’s hard to know what’s real, what’s overhyped, and what any of it actually means if you’re a family dealing with this right now.
So here’s an honest read on where things actually stand.
Mayo Clinic published research in 2025 on a tool called StateViewer. It can look at a single brain scan and identify which of nine different dementia types a person has, and it got it right 88% of the time. It also let clinicians read those scans nearly twice as fast, with up to three times better accuracy than the standard process. That matters because getting a dementia diagnosis currently involves cognitive testing, blood draws, imaging, specialist referrals, and a lot of waiting — sometimes months. A tool that cuts through that with one scan changes the timeline for a lot of families.
Speech analysis is another area worth knowing about. LSU researchers published findings in 2025 showing AI can pick up on subtle changes in how people talk — things like how long they pause before finding a word, how their speech rate shifts, little hesitations that aren’t obvious to the people around them yet. The research found these patterns were sensitive enough to flag mild cognitive impairment before it was showing up in other ways. Your voice, apparently, is sending out signals your brain is giving off way before memory problems become visible to anyone.
And then there’s retinal imaging, which sounds the most like science fiction but is probably the most surprising. Tiny blood vessel changes at the back of the eye may be detectable during early cognitive decline, and AI can be trained to spot them. Researchers are genuinely exploring whether a routine eye scan could serve as an early warning system. A few years ago that sentence would have seemed absurd.
None of this is sitting in your regular doctor’s office. Most of it is still in research institutions, clinical trials, or very early deployment. And early detection, as genuinely promising as it is, doesn’t mean early cure. There’s still no treatment that stops dementia. What earlier detection buys is time. Time to plan. Time to make decisions without urgency. Time to potentially access clinical trials that have enrollment windows. That’s not nothing. It’s actually a lot.
There are also real questions about whether these tools work equally well across different populations. Researchers know this is a problem and are actively working on it, but it’s worth knowing that the science isn’t finished.
Even without AI tools in clinics yet, the direction of this research is changing how people think about dementia. The conversation is slowly shifting from “we noticed something was wrong” to “we saw something changing before it became a problem.” That shift has downstream effects on everything, including when families start thinking about care options and what those conversations look like.
Here’s what we’ve seen at Applewood, over and over. Families who have a little more time — who aren’t making decisions in the middle of a crisis — consistently have an easier time with everything. The visit to the home goes better. The transition goes better. The person moving in has more capacity to adjust. Whatever creates more of that time is worth paying attention to.
If you’re somewhere in the early stages of thinking about what care might eventually look like, we’re happy to talk. No agenda, no pitch. Just a conversation whenever you’re ready.